In fiscal year 2025, Sam-A Pharm (009300) reported revenue of 77.8 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|
| 2025 | 77.8 billion KRW | 11.0 billion KRW | 12.9 billion KRW | [source] |
| 2024 | 95.6 billion KRW | 24.5 billion KRW | 22.1 billion KRW | [source] |
| 2023 | 97.2 billion KRW | 23.5 billion KRW | 21.4 billion KRW | [source] |
| 2022 | 81.7 billion KRW | 18.3 billion KRW | 11.9 billion KRW | [source] |
| 2021 | 54.7 billion KRW | 6.0 billion KRW | 3.4 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|
| 2025 | 247.0 billion KRW | 18.8 billion KRW | 228.1 billion KRW | [source] |
| 2024 | 248.7 billion KRW | 28.7 billion KRW | 220.0 billion KRW | [source] |
| 2023 | 231.3 billion KRW | 30.8 billion KRW | 200.5 billion KRW | [source] |
| 2022 | 203.2 billion KRW | 22.5 billion KRW | 180.6 billion KRW | [source] |
| 2021 | 189.2 billion KRW | 17.1 billion KRW | 172.0 billion KRW | [source] |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|
| 2025 | — | — | — | [source] |
| 2024 | 25.2 billion KRW | -21.4 billion KRW | -3.5 billion KRW | [source] |
| 2023 | 20.8 billion KRW | -20.8 billion KRW | -112 million KRW | [source] |
| 2022 | 19.6 billion KRW | -13.0 billion KRW | -5.4 billion KRW | [source] |
| 2021 | 12.9 billion KRW | -19.8 billion KRW | -3.7 billion KRW | [source] |
Cash flow figures for the relevant year were not collected.
